Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.4.0.3
Document and Entity Information - shares
9 Months Ended
Mar. 31, 2016
May. 09, 2016
Document and Entity Information [Abstract]    
Entity Registrant Name RELMADA THERAPEUTICS, INC.  
Entity Central Index Key 0001553643  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Document Type 10-Q  
Document Period End Date Mar. 31, 2016  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2016  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   12,019,162